Efavirenz-associated podocyte damage [1]

AIDS

Volumn 21, Issue 2, 2007, Pages 257-258

  Barbour, Thomas D ^b   Furlong, Timothy J ^a   Finlayson, Robert J ^c  

^a Nephrology Department   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Taylor Square Private Clinic ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ;

ADULT; CASE REPORT; CELL DAMAGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIDNEY BIOPSY; LABORATORY TEST; LETTER; MALE; NEPHROTOXICITY; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; OXAZINES; PODOCYTES;

EID: 33845927815     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32801120d1     Document Type: Letter

References (5)

1. Angel-Moreno-Maroto A. Severe efavirenz-induced hypersensitivity syndrome (not DRESS) with acute renal failure. J Infect 2006; 52:e39-e40.
2. Nadasdy T, Silva FG, Hogg RJ. Minimal change nephrotic syndrome - focal sclerosis complex. In: Renal pathology: with clinical and functional correlations. Edited by Tisher C.C.CC, Brenner B.M.BM. Philadelphia: JB Lippincott Company; 1994. pp. 330-389.
3. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005; 45:804-817.
4. Daugas E, Rougier J, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int 2005; 67:393-403.
5. Gupta SK, Eustace JA, Winston JA, Boydston II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585.